Log in
(Ad)
Want to know which stocks should be on your radar this week? Every Sunday we send out the 3 Stock Trades that we predict will be big winners for the week ahead.

T2 Biosystems Price Target & Analyst Ratings (NASDAQ:TTOO)

$1.17
+0.03 (+2.63 %)
(As of 01/20/2020 06:07 AM ET)
Today's Range
$1.13
Now: $1.17
$1.20
50-Day Range
$0.99
MA: $1.17
$1.36
52-Week Range
$0.52
Now: $1.17
$5.38
Volume352,491 shs
Average Volume603,946 shs
Market Capitalization$54.62 million
P/E RatioN/A
Dividend YieldN/A
Beta1

Analyst Ratings

T2 Biosystems (NASDAQ:TTOO) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
7 Wall Street analysts have issued ratings and price targets for T2 Biosystems in the last 12 months. Their average twelve-month price target is $5.63, suggesting that the stock has a possible upside of 381.07%. The high price target for TTOO is $10.00 and the low price target for TTOO is $0.40. There are currently 4 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.432.432.502.80
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $5.63$5.63$5.61$8.00
Price Target Upside: 381.07% upside296.38% upside134.83% upside419.48% upside

T2 Biosystems (NASDAQ:TTOO) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

(Ad)


What if you could buy one tiny stock today for $10 - at the center of a growing tech industry - that experts believe will explode a massive 77,400%?

Wall Street legend Paul Mampilly recently identified this as the stock of the century.

Buying up a handful of shares of this small company now could change your life and even make you millions.

T2 Biosystems (NASDAQ:TTOO) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/26/2019Janney Montgomery ScottDowngradeBuy ➝ NeutralHigh
11/21/2019HC WainwrightReiterated RatingHoldMedium
11/13/2019Canaccord GenuityReiterated RatingBuy$3.00High
9/12/2019Leerink SwannSet Price TargetBuy$5.00Low
9/12/2019Svb LeerinkBoost Price TargetOutperform$3.00 ➝ $5.00Medium
8/1/2019Alliance Global PartnersDowngradeBuy ➝ Neutral$5.00 ➝ $0.40High
7/31/2019Cantor FitzgeraldDowngradeOverweight ➝ NeutralHigh
11/30/2018Goldman Sachs GroupSet Price TargetHold$5.00High
(Data available from 1/20/2018 forward)
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel